DOI,paper_doi,paper_title,count_atlas,Publication_PMID,Publication_link_x,count_lnpdb,Index,LNP_ID,Experiment_ID,Formulation_ID,IL_name,IL_SMILES,IL_protonated_SMILES,IL_head_name,IL_head_SMILES,IL_linker_name,IL_linker_SMILES,IL_tail1_name,IL_tail1_SMILES,IL_tail2_name,IL_tail2_SMILES,IL_tail3_name,IL_tail3_SMILES,IL_tail4_name,IL_tail4_SMILES,IL_molratio,IL_to_nucleicacid_massratio,IL_to_nucleicacid_chargeratio,HL_name,HL_SMILES,HL_molratio,CHL_name,CHL_SMILES,CHL_molratio,PEG_name,PEG_SMILES,PEG_molratio,fifthcomponent_name,fifthcomponent_SMILES,fifthcomponent_molratio,Aqueous_buffer,Dialysis_buffer,Mixing_method,Model,Model_type,Model_target,Route_of_administration,Cargo,Cargo_type,Dose_ug_nucleicacid,Experiment_method,Experiment_batching,Experiment_value,Publication_link_y,Heavy.Atoms,Rings,Aromatic.Rings,Rotatable.Bonds,van.der.Waals.Molecular.Volume,Topological.Polar.Surface.Area,Hydrogen.Bond.Donors,Hydrogen.Bond.Acceptors,LogP,Molar.Refractivity,Fraction.sp3.Carbons,sp3.Carbons,Nitrogen.Count,Molecular.Weight,has_ester,has_carbonate,has_disulfide
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19025,LNP_0019025,LZ_2025,LZ_2025_F1,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,ALC-0159,CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.124328357,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19026,LNP_0019026,LZ_2025,LZ_2025_F2,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,ALC-0159,CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.768411598,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19027,LNP_0019027,LZ_2025,LZ_2025_F3,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,ALC-0159,CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.30830825,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19028,LNP_0019028,LZ_2025,LZ_2025_F4,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,ALC-0159,CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.338777885,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19029,LNP_0019029,LZ_2025,LZ_2025_F5,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,ALC-0159,CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.269517802,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19030,LNP_0019030,LZ_2025,LZ_2025_F6,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,ALC-0159,CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.615137926,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19031,LNP_0019031,LZ_2025,LZ_2025_F7,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,DMG-C-PEG2000,CCCCCCCCCCCCCC(O[C@H](COC(CCCCCCCCCCCCC)=O)COC(NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.136060186,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19032,LNP_0019032,LZ_2025,LZ_2025_F8,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,DMG-C-PEG2000,CCCCCCCCCCCCCC(O[C@H](COC(CCCCCCCCCCCCC)=O)COC(NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.834918123,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19033,LNP_0019033,LZ_2025,LZ_2025_F9,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,DMG-C-PEG2000,CCCCCCCCCCCCCC(O[C@H](COC(CCCCCCCCCCCCC)=O)COC(NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.543040973,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19034,LNP_0019034,LZ_2025,LZ_2025_F10,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,DMG-C-PEG2000,CCCCCCCCCCCCCC(O[C@H](COC(CCCCCCCCCCCCC)=O)COC(NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.366313465,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19035,LNP_0019035,LZ_2025,LZ_2025_F11,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,DMG-C-PEG2000,CCCCCCCCCCCCCC(O[C@H](COC(CCCCCCCCCCCCC)=O)COC(NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.535705876,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19036,LNP_0019036,LZ_2025,LZ_2025_F12,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,DMG-C-PEG2000,CCCCCCCCCCCCCC(O[C@H](COC(CCCCCCCCCCCCC)=O)COC(NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.852365048,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19037,LNP_0019037,LZ_2025,LZ_2025_F13,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,DMG-PEG2000,O=C(CCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.107617552,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19038,LNP_0019038,LZ_2025,LZ_2025_F14,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,DMG-PEG2000,O=C(CCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.238886193,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19039,LNP_0019039,LZ_2025,LZ_2025_F15,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,DMG-PEG2000,O=C(CCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.053995196,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19040,LNP_0019040,LZ_2025,LZ_2025_F16,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,DMG-PEG2000,O=C(CCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.576134586,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19041,LNP_0019041,LZ_2025,LZ_2025_F17,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,DMG-PEG2000,O=C(CCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.667811871,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19042,LNP_0019042,LZ_2025,LZ_2025_F18,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,DMG-PEG2000,O=C(CCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.831599981,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19043,LNP_0019043,LZ_2025,LZ_2025_F19,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,DSG-PEG2000,O=C(CCCCCCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.501075834,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19044,LNP_0019044,LZ_2025,LZ_2025_F20,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,DSG-PEG2000,O=C(CCCCCCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.761432844,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19045,LNP_0019045,LZ_2025,LZ_2025_F21,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,DSG-PEG2000,O=C(CCCCCCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.832571825,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19046,LNP_0019046,LZ_2025,LZ_2025_F22,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,DSG-PEG2000,O=C(CCCCCCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.829397135,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19047,LNP_0019047,LZ_2025,LZ_2025_F23,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,DSG-PEG2000,O=C(CCCCCCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.852203074,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19048,LNP_0019048,LZ_2025,LZ_2025_F24,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,DSG-PEG2000,O=C(CCCCCCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.846413392,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19049,LNP_0019049,LZ_2025,LZ_2025_F25,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,C8-Ceramide-PEG2000,[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCC)=O)COC(CCC(OOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.554077778,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19050,LNP_0019050,LZ_2025,LZ_2025_F26,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,C8-Ceramide-PEG2000,[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCC)=O)COC(CCC(OOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.423623917,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19051,LNP_0019051,LZ_2025,LZ_2025_F27,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,C8-Ceramide-PEG2000,[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCC)=O)COC(CCC(OOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.74433735,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19052,LNP_0019052,LZ_2025,LZ_2025_F28,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,C8-Ceramide-PEG2000,[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCC)=O)COC(CCC(OOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.50030732,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19053,LNP_0019053,LZ_2025,LZ_2025_F29,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,C8-Ceramide-PEG2000,[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCC)=O)COC(CCC(OOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.255758973,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19054,LNP_0019054,LZ_2025,LZ_2025_F30,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,C8-Ceramide-PEG2000,[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCC)=O)COC(CCC(OOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.833104014,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19055,LNP_0019055,LZ_2025,LZ_2025_F31,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,C16-Ceramide-PEG2000,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.318123875,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19056,LNP_0019056,LZ_2025,LZ_2025_F32,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,C16-Ceramide-PEG2000,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.398611081,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19057,LNP_0019057,LZ_2025,LZ_2025_F33,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,C16-Ceramide-PEG2000,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.454524506,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19058,LNP_0019058,LZ_2025,LZ_2025_F34,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,C16-Ceramide-PEG2000,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.607265989,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19059,LNP_0019059,LZ_2025,LZ_2025_F35,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,C16-Ceramide-PEG2000,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.645880591,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19060,LNP_0019060,LZ_2025,LZ_2025_F36,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,C16-Ceramide-PEG2000,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.789843084,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19061,LNP_0019061,LZ_2025,LZ_2025_F37,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.968703737,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19062,LNP_0019062,LZ_2025,LZ_2025_F38,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.232018496,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19063,LNP_0019063,LZ_2025,LZ_2025_F39,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.271688254,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19064,LNP_0019064,LZ_2025,LZ_2025_F40,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.690099494,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19065,LNP_0019065,LZ_2025,LZ_2025_F41,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.743097387,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19066,LNP_0019066,LZ_2025,LZ_2025_F42,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.822626621,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19067,LNP_0019067,LZ_2025,LZ_2025_F43,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,DSPE-PEG2000,CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCCCCCCC,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.497641985,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19068,LNP_0019068,LZ_2025,LZ_2025_F44,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,DSPE-PEG2000,CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCCCCCCC,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.786020497,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19069,LNP_0019069,LZ_2025,LZ_2025_F45,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,DSPE-PEG2000,CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCCCCCCC,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.862407436,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19070,LNP_0019070,LZ_2025,LZ_2025_F46,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,DSPE-PEG2000,CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCCCCCCC,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.864383519,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19071,LNP_0019071,LZ_2025,LZ_2025_F47,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,DSPE-PEG2000,CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCCCCCCC,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.86175954,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19072,LNP_0019072,LZ_2025,LZ_2025_F48,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,DSPE-PEG2000,CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCCCCCCC,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,HepG2,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.865322968,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19073,LNP_0019073,LZ_2025,LZ_2025_F49,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,ALC-0159,CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.609355016,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19074,LNP_0019074,LZ_2025,LZ_2025_F50,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,ALC-0159,CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.069339062,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19075,LNP_0019075,LZ_2025,LZ_2025_F51,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,ALC-0159,CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.149920778,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19076,LNP_0019076,LZ_2025,LZ_2025_F52,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,ALC-0159,CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.17546823,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19077,LNP_0019077,LZ_2025,LZ_2025_F53,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,ALC-0159,CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.766998165,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19078,LNP_0019078,LZ_2025,LZ_2025_F54,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,ALC-0159,CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.035808908,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19079,LNP_0019079,LZ_2025,LZ_2025_F55,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,DMG-C-PEG2000,CCCCCCCCCCCCCC(O[C@H](COC(CCCCCCCCCCCCC)=O)COC(NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.89286723,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19080,LNP_0019080,LZ_2025,LZ_2025_F56,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,DMG-C-PEG2000,CCCCCCCCCCCCCC(O[C@H](COC(CCCCCCCCCCCCC)=O)COC(NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.664608054,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19081,LNP_0019081,LZ_2025,LZ_2025_F57,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,DMG-C-PEG2000,CCCCCCCCCCCCCC(O[C@H](COC(CCCCCCCCCCCCC)=O)COC(NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.521395543,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19082,LNP_0019082,LZ_2025,LZ_2025_F58,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,DMG-C-PEG2000,CCCCCCCCCCCCCC(O[C@H](COC(CCCCCCCCCCCCC)=O)COC(NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.410503297,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19083,LNP_0019083,LZ_2025,LZ_2025_F59,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,DMG-C-PEG2000,CCCCCCCCCCCCCC(O[C@H](COC(CCCCCCCCCCCCC)=O)COC(NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.693647947,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19084,LNP_0019084,LZ_2025,LZ_2025_F60,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,DMG-C-PEG2000,CCCCCCCCCCCCCC(O[C@H](COC(CCCCCCCCCCCCC)=O)COC(NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.076935045,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19085,LNP_0019085,LZ_2025,LZ_2025_F61,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,DMG-PEG2000,O=C(CCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.952308775,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19086,LNP_0019086,LZ_2025,LZ_2025_F62,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,DMG-PEG2000,O=C(CCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.215804649,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19087,LNP_0019087,LZ_2025,LZ_2025_F63,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,DMG-PEG2000,O=C(CCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.184884111,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19088,LNP_0019088,LZ_2025,LZ_2025_F64,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,DMG-PEG2000,O=C(CCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.532302272,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19089,LNP_0019089,LZ_2025,LZ_2025_F65,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,DMG-PEG2000,O=C(CCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.927617399,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19090,LNP_0019090,LZ_2025,LZ_2025_F66,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,DMG-PEG2000,O=C(CCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.078362614,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19091,LNP_0019091,LZ_2025,LZ_2025_F67,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,DSG-PEG2000,O=C(CCCCCCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.578014855,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19092,LNP_0019092,LZ_2025,LZ_2025_F68,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,DSG-PEG2000,O=C(CCCCCCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.887797335,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19093,LNP_0019093,LZ_2025,LZ_2025_F69,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,DSG-PEG2000,O=C(CCCCCCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.017189762,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19094,LNP_0019094,LZ_2025,LZ_2025_F70,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,DSG-PEG2000,O=C(CCCCCCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.063509822,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19095,LNP_0019095,LZ_2025,LZ_2025_F71,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,DSG-PEG2000,O=C(CCCCCCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.0774514,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19096,LNP_0019096,LZ_2025,LZ_2025_F72,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,DSG-PEG2000,O=C(CCCCCCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.066243464,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19097,LNP_0019097,LZ_2025,LZ_2025_F73,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,C8-Ceramide-PEG2000,[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCC)=O)COC(CCC(OOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.177348327,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19098,LNP_0019098,LZ_2025,LZ_2025_F74,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,C8-Ceramide-PEG2000,[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCC)=O)COC(CCC(OOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.85577773,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19099,LNP_0019099,LZ_2025,LZ_2025_F75,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,C8-Ceramide-PEG2000,[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCC)=O)COC(CCC(OOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.979459881,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19100,LNP_0019100,LZ_2025,LZ_2025_F76,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,C8-Ceramide-PEG2000,[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCC)=O)COC(CCC(OOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.312633274,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19101,LNP_0019101,LZ_2025,LZ_2025_F77,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,C8-Ceramide-PEG2000,[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCC)=O)COC(CCC(OOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.477289693,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19102,LNP_0019102,LZ_2025,LZ_2025_F78,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,C8-Ceramide-PEG2000,[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCC)=O)COC(CCC(OOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.273089653,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19103,LNP_0019103,LZ_2025,LZ_2025_F79,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,C16-Ceramide-PEG2000,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.343310821,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19104,LNP_0019104,LZ_2025,LZ_2025_F80,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,C16-Ceramide-PEG2000,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.388692371,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19105,LNP_0019105,LZ_2025,LZ_2025_F81,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,C16-Ceramide-PEG2000,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.504811444,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19106,LNP_0019106,LZ_2025,LZ_2025_F82,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,C16-Ceramide-PEG2000,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.633657142,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19107,LNP_0019107,LZ_2025,LZ_2025_F83,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,C16-Ceramide-PEG2000,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.400662183,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19108,LNP_0019108,LZ_2025,LZ_2025_F84,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,C16-Ceramide-PEG2000,CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.845274002,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19109,LNP_0019109,LZ_2025,LZ_2025_F85,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.632621354,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19110,LNP_0019110,LZ_2025,LZ_2025_F86,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.645077695,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19111,LNP_0019111,LZ_2025,LZ_2025_F87,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.045468327,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19112,LNP_0019112,LZ_2025,LZ_2025_F88,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.738145577,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19113,LNP_0019113,LZ_2025,LZ_2025_F89,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.929287959,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19114,LNP_0019114,LZ_2025,LZ_2025_F90,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.052848615,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19115,LNP_0019115,LZ_2025,LZ_2025_F91,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.8,DSPE-PEG2000,CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCCCCCCC,0.5,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.705341863,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19116,LNP_0019116,LZ_2025,LZ_2025_F92,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,43.3,DSPE-PEG2000,CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCCCCCCC,1.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.024509851,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19117,LNP_0019117,LZ_2025,LZ_2025_F93,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,42.7,DSPE-PEG2000,CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCCCCCCC,1.6,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.077724764,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19118,LNP_0019118,LZ_2025,LZ_2025_F94,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,41.3,DSPE-PEG2000,CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCCCCCCC,3.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.076965419,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19119,LNP_0019119,LZ_2025,LZ_2025_F95,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,39.3,DSPE-PEG2000,CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCCCCCCC,5.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.086988776,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
10.1016/j.jconrel.2025.01.071,https://doi.org/10.1016/j.jconrel.2025.01.071,Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines,13,39875076.0,https://doi.org/10.1016/j.jconrel.2025.01.071,96,19120,LNP_0019120,LZ_2025,LZ_2025_F96,ALC-0315,CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO,CCCCCCCCC(CCCCCC)C(=O)OCCCCCC[N+](CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCO)[H],,,,,,,,,,,,,46.3,13.93,6.0,DSPC,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,9.4,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,34.3,DSPE-PEG2000,CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCCCCCCC,10.0,None,,0.0,acetate,PBS,handmixed,in_vitro,A549,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.089054195,https://doi.org/10.1016/j.jconrel.2025.01.071,54,0,0,44,765.7210251,76.07,1,6,13.9425,232.0978,0.958333333,2,1,766.29,True,False,False
